Optimal long-term antithrombotic treatment of patients with stable coronary artery disease and atrial fibrillation: “OLTAT registry”

References

Page 1

	Year	Citations
Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach Gregory Y.H. Lip, Robby Nieuwlaat, Ron Pisters, CHEST Journal ThrombosisVenous ThrombosisCardiovascular EpidemiologyIschemic StrokeCardiovascular Disease	2009	6.6K
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS Paulus Kirchhof, Stefano Benussi, Dipak Kotecha, European Heart Journal	2016	6.4K
A Novel User-Friendly Score (HAS-BLED) To Assess 1-Year Risk of Major Bleeding in Patients With Atrial Fibrillation Ron Pisters, Deirdre A. Lane, Robby Nieuwlaat, CHEST Journal Acute Myocardial InfarctionThrombosisStrokeBleeding DisorderPublic Health	2010	4.4K
Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease John W. Eikelboom, Stuart J. Connolly, Jackie Bosch, New England Journal of Medicine	2017	2.3K
2016 ESC Guidelines for the Management of Atrial Fibrillation Developed in Collaboration With EACTS Paulus Kirchhof, Stefano Benussi, Dipak Kotecha, Revista Española de Cardiología (English Edition) Electrophysiological EvaluationCardiovascular DiseasePatient SafetyAtrial FibrillationPublic Health	2016	1.8K
Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial Willem J.M. Dewilde, Tom Oirbans, Freek W.A. Verheugt, The Lancet Percutaneous Coronary InterventionThrombosisCardiovascular DiseaseOral Anticoagulant TherapyCoronary Artery Disease	2013	1.7K
Warfarin, Aspirin, or Both after Myocardial Infarction Mette Hurlen, Michael Abdelnoor, Pål Smith, New England Journal of Medicine	2002	847
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary Craig T. January, L. Samüel Wann, Joseph S. Alpert, Journal of the American College of Cardiology ThrombosisCardiovascular DiseasePatient SafetyAha/acc/hrs GuidelineCardiac Care	2014	577
Risk of bleeding in patients with acute myocardial infarction treated with different combinations of aspirin, clopidogrel, and vitamin K antagonists in Denmark: a retrospective analysis of nationwide registry data Rikke Sørensen, Morten Lock Hansen, Steen Z. Abildstrøm, The Lancet ThrombosisCardiovascular EpidemiologyCardiovascular DiseaseNationwide Registry DataPharmacotherapy	2009	570
Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary or valve interventions: a joint consensus document of the European Society of Cardiology Working Group on Thrombosis, European Heart Rhythm Association (EHRA), European Association of Percutaneous Cardiovascular Interventions (EAPCI) and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS) and Asia-Pacific Heart Rhythm Society (APHRS) European Heart Journal	2014	559

Page 1